SG11201901983PA - Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole - Google Patents

Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole

Info

Publication number
SG11201901983PA
SG11201901983PA SG11201901983PA SG11201901983PA SG11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA
Authority
SG
Singapore
Prior art keywords
basel
roche
group
international
grenzacherstrasse
Prior art date
Application number
SG11201901983PA
Inventor
Bjoern Bartels
Philipp Cueni
Matthias Koerner
Dieter Muri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201901983PA publication Critical patent/SG11201901983PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111101111 0 1110101011111 011101 0 0111111111111111111111111111111111111110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/046428 Al 15 March 2018 (15.03.2018) WI P0 I P C T (51) International Patent Classification: strasse 124, 4070 Basel (CH). MURI, Dieter; c/o F. Hoff- C07D 471/04 (2006.01) mann-La Roche AG, Grenzacherstrasse 124, 4070 Basel (21) International Application Number: (CH). PCT/EP2017/072062 (74) Agent: POPPE, Regina; Grenzacherstrasse 124, 4070 (22) International Filing Date: Basel (CH). 04 September 2017 (04.09.2017) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (30) Priority Data: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 16187960.6 09 September 2016 (09.09.2016) EP HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (71) Applicant (for all designated States except US): F. HOFF- MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, MANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 124, 4070 Basel (CH). SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for US only): HOFFMANN-LA ROCHE INC. [US/US]; Overlook at Great Notch, 150 Clove Road, (84) Designated States (unless otherwise indicated, for every _ 8th Floor, Suite 8 - Legal Department, Little Falls, New Jer- kind of regional protection available): ARIPO (BW, GH, sey 07424 (US). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, — (72) Inventors: BARTELS, Bjoern; c/o F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel (CH). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fk FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, _ — CUENI, Philipp; c/o F. Hoffmann-La Roche AG, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, Grenzacherstrasse 124, 4070 Basel (CH). KOERNER, Matthias; c/o F. Hoffmann-La Roche AG, Grenzacher- = _ = _ Title: PROCESS FOR PREPARATION OF 2-(6-NITROPYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B;3',4'-D]PYRROLE = (54) = = (57) : The present invention relates to a process for preparation of the compound — of formula (I) which processes comprise: a) coupling a compound of formula (2), wherein a / \ — = — 1 p leaving group 0-502-R is selected from the triflate group, the tosylate group, the mesylate ,,, N - / N ' - group, the besylate group, the nosylate group or the brosylate group, with a suitable boronic o I acid, a trifluoroborate or a boronic acid ester under argon condition and in the presence of a = = catalyst and a base in a suitable solvent and then isolating the product as an acid addition salt to afford the compound of formula (Ia) and b) converting the acid addition salt of formula (Ia) wherein the acid HX comprises suitable organic or inorganic acids into the compound of = — \ formula (I) by treatment with at least a stoichiometric equivalent of a suitable base. = N N O' S°2-R = H 2, = = = / \ o N N. N N 0 11 x HX Ia GC ei ii- \ . ____ 0 ,-.... N N N+ N H 0 I 11 ei C [Continued on next page] WO 2018/046428 Al O II TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3))
SG11201901983PA 2016-09-09 2017-09-04 Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole SG11201901983PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16187960 2016-09-09
PCT/EP2017/072062 WO2018046428A1 (en) 2016-09-09 2017-09-04 Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole

Publications (1)

Publication Number Publication Date
SG11201901983PA true SG11201901983PA (en) 2019-04-29

Family

ID=56936288

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901983PA SG11201901983PA (en) 2016-09-09 2017-09-04 Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole

Country Status (18)

Country Link
US (1) US11306093B2 (en)
EP (1) EP3510031B1 (en)
JP (1) JP6997769B2 (en)
KR (1) KR102502701B1 (en)
CN (1) CN109689653B (en)
AR (1) AR109586A1 (en)
AU (1) AU2017324297B2 (en)
BR (1) BR112019004091B1 (en)
CA (1) CA3035624A1 (en)
ES (1) ES2847903T3 (en)
HR (1) HRP20210145T1 (en)
IL (1) IL265013B (en)
MX (1) MX2019002362A (en)
PL (1) PL3510031T3 (en)
SG (1) SG11201901983PA (en)
SI (1) SI3510031T1 (en)
TW (1) TWI753009B (en)
WO (1) WO2018046428A1 (en)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044152A1 (en) * 2003-05-09 2005-08-24 Bayer Corp RENTAL DERIVATIVES, METHOD OF PREPARATION AND USE FOR THE TREATMENT OF OBESITY
FR2876377B1 (en) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon NOVEL 9H-PYRIDO [2,3-B] INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
ES2907992T3 (en) 2008-02-14 2022-04-27 Lilly Co Eli Novel Imaging Agents to Detect Neurological Dysfunctions
KR101764556B1 (en) 2008-06-11 2017-08-02 제넨테크, 인크. Diazacarbazoles and methods of use
JP2011529086A (en) 2008-07-24 2011-12-01 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Contrast agents useful for identifying AD lesions
US20100056491A1 (en) * 2008-08-29 2010-03-04 Memory Pharmaceuticals Corporation 4'-amino cyclic compounds having 5-ht6 receptor affinity
EP2411057B1 (en) 2009-03-23 2020-05-06 Eli Lilly and Company Imaging agents for detecting neurological disorders
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
US20110183938A1 (en) 2009-12-16 2011-07-28 Genentech, Inc. 1,7-diazacarbazoles and methods of use
US20150368244A1 (en) 2011-01-31 2015-12-24 Genentech, Inc. Diazacarbazoles and methods of use
PL3141548T3 (en) 2011-07-05 2020-09-07 Vertex Pharmaceuticals Incorporated Processes and intermediates for producing azaindoles
JP6034005B2 (en) * 2011-08-03 2016-11-30 出光興産株式会社 Biscarbazole derivative and organic electroluminescence device using the same
EP3055308B1 (en) * 2013-10-08 2017-11-22 F.Hoffmann-La Roche Ag Diazacarbazole derivatives as tau-pet-ligands
MX2017009505A (en) 2015-02-02 2017-11-02 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives.
JP6831372B2 (en) * 2015-09-09 2021-02-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Crosslinked piperidine derivative

Also Published As

Publication number Publication date
IL265013B (en) 2021-09-30
MX2019002362A (en) 2019-06-17
HRP20210145T1 (en) 2021-03-05
KR102502701B1 (en) 2023-02-23
WO2018046428A1 (en) 2018-03-15
BR112019004091A2 (en) 2019-05-28
CA3035624A1 (en) 2018-03-15
TWI753009B (en) 2022-01-21
US11306093B2 (en) 2022-04-19
KR20190044648A (en) 2019-04-30
JP6997769B2 (en) 2022-02-10
ES2847903T3 (en) 2021-08-04
CN109689653A (en) 2019-04-26
SI3510031T1 (en) 2021-03-31
CN109689653B (en) 2022-04-12
EP3510031A1 (en) 2019-07-17
AR109586A1 (en) 2018-12-26
BR112019004091B1 (en) 2023-02-14
US20190300529A1 (en) 2019-10-03
AU2017324297B2 (en) 2021-08-05
EP3510031B1 (en) 2020-12-02
TW201811787A (en) 2018-04-01
AU2017324297A1 (en) 2019-03-14
JP2019529401A (en) 2019-10-17
PL3510031T3 (en) 2021-05-31

Similar Documents

Publication Publication Date Title
SG11201901700UA (en) Biaryl compounds useful as immunomodulators
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201809913PA (en) Methods for detecting target nucleic acids in a sample
SG11201908640TA (en) Pyrrolidinones and a process to prepare them
SG11201909433XA (en) Targeted compositions
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201901834WA (en) Micrornas as biomarkers for endometriosis
SG11201804890TA (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
SG11201805709RA (en) Anti-pro/latent myostatin antibodies and methods of use thereof
SG11201903582UA (en) Settlement method, entrance control method, and apparatus
SG11201906844RA (en) Biometric feature database establishing method and apparatus
SG11201805166PA (en) Light-mediated polymerase chain reaction amplification and product detection system and methods of use
SG11201811336TA (en) Method for producing an electrode catalyst from a perovskite metal oxide
SG11201908127WA (en) Method for producing multispecific antibodies
SG11201805115PA (en) Detection and quantification of target nucleic acid sequence of a microorganism
SG11201907364WA (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201807038UA (en) Rodents having a humanized tmprss gene
SG11201807382RA (en) A single- or multiple component composition for producing a hydrogel
SG11201806393QA (en) Use of gabaa receptor modulators for treatment of itch
SG11201807775SA (en) Aqueous polymer dispersions, a method for their preparation and the use thereof as pour-point depressants for crude oil, petroleum, and petroleum products
SG11201906807VA (en) Compositions and methods for promoting hair growth with mpc1 inhibitors
SG11201908605XA (en) Antifouling article
SG11201805263TA (en) Compositions and methods for detecting and treating esophageal cancer